2. Gene
  3. NPS - neuropeptide S Gene

NPS - neuropeptide S Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens
Gene ID: 594857 | Gene type: protein coding

About NPS

Cytogenetic location: 10q26.2 Genomic coordinates (GRCh38): 10:127,549,309-127,553,540 (from NCBI)

This gene has 1 transcript (splice variant) and 104 orthologues.

Summary

Predicted to be involved in positive regulation of GABAergic synaptic transmission; positive regulation of action potential; and positive regulation of glutamatergic synaptic transmission. Predicted to act upstream of or within visual learning. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

NPS Products(1)

mRNA Protein Name
NM_001030013.2 NP_001025184.1 neuropeptide S precursor

NPS Protein Structure

Neuropeptide_S

Neuropeptide_S: Neuropeptide S precursor protein (24 - 88)

  • 0
  • 89 a.a.
Protein Preferred Names Protein Names

neuropeptide S

prepro-neuropeptide S

Related Diseases

Diseases Alias
Anxiety

Anxiety Disorder

Anxiety Disorders

Anxiety State

Anxieties

Anxiety Neurosis
Functional Colonic Disease

Colonic Diseases, Functional
Colonic Pseudo-Obstruction

Primary Chronic Pseudo-Obstruction Of Colon
Phobia, Specific

Specific Phobia

Simple Phobia

Phobia, Simple

Isolated Phobia
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Clinical Phase
Bioactive Molecules (3)
Cat. No. Product Name Effect
Purity Phase
HY-17633 Fonadelpar Agonist / Phase 3
HY-10007 NPS-2143 Antagonist 99.33% Phase 2
HY-106397 Delucemine / Phase 1
Pre-clinical Phase
Bioactive Molecules (17)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-152229 G0-C14 ≥98.0% Unkown
HY-11095 NPS 2390 98.83% Unkown
HY-10171 NPS-2143 hydrochloride Antagonist 99.80% Unkown
HY-D1724 IR-806 ≥97.0% Unkown
HY-100509 NPS-1034 ≥98.0% Unkown
HY-P2491 Atrial Natriuretic Peptide (1-28), human, porcine, Biotin-labeled 99.81% Unkown
HY-108626 ML154 Antagonist 98.02% Unkown
HY-121870A Dimethocaine hydrochloride 99.36% Unkown
HY-103090 NPS ALX Compound 4a Antagonist ≥99.0% Unkown
HY-P1438 Neuropeptide S(Rat) Agonist 99.57% Unkown
HY-103090A NPS ALX Compound 4a dihydrochloride Antagonist / Unkown
HY-159702 Eudragit RS 100 Activator / Unkown
HY-D2314 Cyanine 7-amine chloride hydrochloride / Unkown
HY-RS09502 NPS Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-106397A Delucemine hydrochloride / Unkown
HY-138232 Lys-psi(CH2NH)-Trp(Nps)-OMe / Unkown
HY-W010713 Meso-tetraphenylchlorin / Unkown

Orthologs Information

Species Symbol Source ID
Canis familiaris NPS VGNC VGNC:53003
Macaca mulatta NPS VGNC VGNC:106083
Bos taurus NPS VGNC VGNC:107301
Rattus norvegicus NPS RGD RGD:2324597
Mus musculus NPS MGD MGI:3642232